Breast Cancer

  1. Verzenio (abemaciclib)
    Verzenio (abemaciclib)
    by Lilly
    for Breast Cancer
    €5,520.00
  2. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,880.00
  3. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €5,016.00
  4. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  5. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,988.60
View as Grid List

5 Items

per page
Set Descending Direction